Drugs Similar to D-99

Uses: For temporary relief of minor: fatigue* headache* lymphatic swelling* muscle cramps* urinary discomfort* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses: For temporary relief of minor: fatigue* headache* muscle aches and cramps* irritability* water retention* sadness* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses: For temporary relief of minor: intestinal discomfort* headaches* muscle aches* coughing* skin itching* flatulence* constipation* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses: For temporary relief of minor: spasms* fatigue* headache* congestion* dry skin* nervous irritability* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses: For temporary relief of minor: fatigue* irritability* lack of appetite* nervous exhaustion* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Uses: For temporary relief of minor: rash* sore throat* constipation* headache* coughing* muscle soreness* swollen ankle* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

APPLY TO THE PREVIOUSLY MOISTENED EXTERNAL INTIMATE REGION. SPREAD UNTIL FOAMY. RINSE THOROUGHLY AFTER USE

Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact. Rx Only. Single use container. For use only with apheresis devices. See apheresis device operator's manual for complete instructions.

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is designed to be metered by an apheresis device in apheresis procedures, to prevent platelet activation and coagulation as blood moves throughout the extracorporeal unit (tubing set) in an apheresis procedure. The solution is sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents. The formulas of the active ingredients are provided in Table 1. Table 1: Active Ingredients Ingredients Molecular Formula Molecular Weight (%w/v) Citric Acid, Monohydrate C 6 H 8 O 7 192.12 Dextrose Monohydrate C 6 H 12 O 6 ∙ H 2 O 198.17 Sodium Citrate Dihydrate C 6 H 9 Na 3 O 9 294.10 Water for Injection H 2 O 18.00 Each 100 mL of ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A contains: (%w/v) Citric Acid, Monohydrate 0.8 g; Dextrose Monohydrate 2.45 g; Sodium Citrate Dihydrate 2.2 g; and Water for Injection. The polyolefin bag is not made with natural rubber latex or PVC. The bag is made from a multilayered film. It contains materials that have been tested to demonstrate the suitability of the container for storing pharmaceutical solutions. The solution contact layer is an elasticized polyolefin. The bag is nontoxic and biologically inert. The bag-solution unit is a closed system and is not dependent upon entry of external air during administration. The bag is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

INDICATIONS & USAGE SECTION Formulated for symptoms associated with acne and other skin conditions such as boils, pimples, pustules and sebaceous cysts.

INDICATIONS & USAGE SECTION Formulated for symptoms associated with acne and other skin conditions such as boils, pimples, pustules and sebaceous cysts.

INDICATIONS & USAGE SECTION Formulated for symptoms associated with acne such as boils, pimples, pustules, and sebaceous cysts.

INDICATIONS: For temporary relief of eruptions due to acne.

USES: Temporarily relieves eruptions, rashes, itchy skin &/or other symptoms related to acne.**

USES: Temporarily relieves pustular eruptions, acne simplex and indurate. Helps prevent recurrence of bluish red and acne eruptions.**

INDICATIONS: Temporarily relieves acne discomfort and the common symptoms of acne, including: ° Face and body breakouts ° redness ° itching and inflammation ° natural ° gluten & lactose free ° no artificial flavors or colors ° no known negative side effects ° no known negative drug interactions

USES: • For the temporary relief of symptoms related to food additives including: • muscle weakness • skin irritation • poor muscle coordination • headache • liver support These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

USES: • For the temporary relief of symptoms including: • headache • liver support • muscle weakness • skin irritation • poor muscle coordination These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to food additives, herbicides and insecticides including muscle weakness, skin irritation, poor muscle coordination, headache, cough, occasional diarrhea, dizziness, fatigue, fever, stomach pain and vomiting.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

ADDITIVE SOLUTION FORMULA 3 (AS-3) is designed to be added to packed RBC collected in apheresis procedures, and acts to preserve and extend the shelf life of packed RBC products for later transfusion to patients. The solution is intended to be metered by an apheresis device during apheresis procedures or added manually after a collection. Additive Solution Formula 3 (AS-3) is a clear solution that is steam-sterilized and non-pyrogenic. It does not contain bacteriostatic or antimicrobial agents. The formulas of the active ingredients are provided in Table 1. Table 1: Active Ingredients Ingredients Molecular Formula Molecular Weight Dextrose Monohydrate USP C 6 H 12 O 6 ∙ H 2 O 198.17 Trisodium Citrate Dihydrate USP C 6 H 9 Na 3 O 9 294.10 Sodium Chloride USP NaCl 58.44 Monobasic Sodium Phosphate Monohydrate USP NaH 2 PO 4 ∙ H 2 O 137.99 Citric Acid Monohydrate USP C 6 H 8 0 7 ∙ H 2 O 210.14 Adenine USP C 5 H 5 N 5 135.13 Water for Injection USP H 2 O 18.00 Each 100 mL of ADDITIVE SOLUTION FORMULA 3 (AS-3) contains: Dextrose Monohydrate USP 1.10 g; Trisodium Citrate Dihydrate USP 0.59 g; Sodium Chloride USP 0.41 g; Monobasic Sodium Phosphate Monohydrate USP 0.28 g; Citric Acid Monohydrate USP 0.042 g; Adenine USP 0.03 g; and Water for Injection USP. ADDITIVE SOLUTION FORMULA 3 is available in three volumes: 100 mL, 200 mL and 350 mL. The 100 mL bags are individually wrapped with a clear plastic film. Six individually wrapped bags are then vacuum-sealed in a foil pouch, which serves as a vapor barrier to prevent water loss during storage. After you remove the individual solution bags from the foil pouch, you can either leave them in the clear plastic film or remove and discard it. Once the foil pouch has been opened, use all six of the solution bags within 2 weeks. The 200 mL and 350 mL bags are individually wrapped with a clear plastic film. These larger volumes do not require the additional vapor barrier. Once the clear plastic film has been removed, use the solution within 2 weeks. The Polyolefin bag is not made with natural rubber latex. The bag is made from a multilayered film. It contains materials that have been tested to demonstrate the suitability of the container for storing pharmaceutical solutions. The bag is nontoxic and biologically inert. The bag-solution unit is a closed system and is not dependent upon entry of external air during administration.

INDICATIONS Conditions of nervous exhaustion.

INDICATIONS Heavy metal detox.